World ADC 2026
We will attend World ADC 2026
Meet Charlotte Lentz, Louis Lefebvre and Géry Van Vyncht to discuss your ADC programmes.
How we support your ADC development
We help biopharma teams advance mAbs, ADCs and complex biotherapeutics by combining our experience in monoclonal antibodies, highly potent small-molecule and all major conjugation strategies (lysine, cysteine, site-specific).
Our key ADCs services
- ADC characterisation (intact, sub-unit, peptide)
- Analytical development
- Potency assays & bioanalysis
- Stability studies & batch testing
All performed in a GMP, GLP, GcLP/GCP environment.
Discover our complete ADCs services
Schedule a meeting to discuss your analytical needs and how we can support your ADC development.